Mycetoma

REFERENCES

• Avram A., Nicolau G. Attempts to demonstrate complement fixing antibodies in mycetoma. Mycopathologia et Mycologia Applicata 1969; 39: 367–370
   PubMedGoogle Scholar
• Bendi B.J., Mackey D., Al-Saati F., Sheth K.V., Ofole S.N., Bailey T.M. Mycetoma in Saudi Arabia. Journal of Tropical Medicine and Hygiene 1987; 90: 51–59
   PubMed Web of Science ®Google Scholar
• Blumer S.O., Kaufman L. Microimmunodiffusion test for nocardiosis. Journal of Clinical Microbiology 1979; 10: 308–312
   PubMed Web of Science ®Google Scholar
• Dixon J.M. Sulfanilamide therapy in madura foot. Virginia Medical Monthly 1941; 68: 281–282
   Google Scholar
• Fanning W.L., Gump D.W., Sofferman R.A. Side effects of minocycline: a double-blind study. Antimicrobial Agents and Chemotherapy 1977; 11: 712–717
   PubMed Web of Science ®Google Scholar
• Findlay G.H., Vismer H.F. Black grain mycetoma. A study of the chemistry, formation and significance of the tissue grain in Madurella mycetomi infection. British Journal of Dermatology 1974; 91: 297–303
   PubMed Web of Science ®Google Scholar
• Garcia M. Sulfonas en el tratamiento del micetoma, estudio de un caso. Prensa Medica Mexicana 1950; 15: 282–284
   Google Scholar
• Gonzalez Ochoa A., Little Brown Co. Boston. Effectiviness of DDS in the treatment of chromoblastomycosis and of mycetoma caused by Nocardia brasiliensis. Therapy of Fungus Diseases. 1955; 321–37, In
   Google Scholar
• Gonzalez Ochoa A., Schiels J., Vazquez P. Acción de la 4.4 — diamino difenilsulfona frente a Nocardia brasiliensis. Gaceta Medica de Mexico 1952; 82: 345–353
   PubMedGoogle Scholar
• Gonzalez Ochoa A., Tamayo L. Tratamiento del micetoma actinomicetico por Nocardia brasiliensis con. R06-2580. Revista Mexicana Dermatologia 1969; 49: 473–476
   Google Scholar
• Gumaa S.A., Mahgoub E.S. Counterimmunoelectrophoresis in the diagnosis of mycetoma and its sensitivity as compared to immunodiffusion. Sabouraudia 1975; 13: 309–315
   PubMedGoogle Scholar
• Gumaa S.A., Mahgoub E.S., el Sid M.A. Mycetoma of the head and neck. American Journal of Tropical Medicine and Hygiene 1986; 35: 594–600
   PubMed Web of Science ®Google Scholar
• Hay R.J. Ketoconazole in the treatment of fungal infections. Clinical and laboratory studies. American Journal of Medicine 1983; 74(Suppl. 1B)16–19
   PubMedGoogle Scholar
• Hay R.J., Collins M.J. An ultrastructural study of pale eumycetoma grains. Sabouraudia 1983; 21: 261–269
   PubMedGoogle Scholar
• Hubler W.R., Jr., Hubler W.R. Actinomycotic mycetoma treated with minocycline: case report. Texas Medicine 1976; 72: 79–83
   PubMedGoogle Scholar
• Kamalam A., Thambiah A.S. A clinico-pathological study of actinomycotic mycetomas caused by Actinomadura madurae and Actinomadura pelletierii. Mycopathologia 1987; 97: 151–163
   PubMed Web of Science ®Google Scholar
• Katz S.A. Commentary: Sulfoxone (Diasone) in the treatment of dermatitis herpetiformis. Archives of Dermatology 1982; 118: 805–812
   PubMedGoogle Scholar
• Kawaguchi H., Naito T., Nakagawa S., Fugijawa K. BB-K8, A new semisynthetic aminoglycoside antibiotic. Journal of Antibiotics (Tokyo) 1972; 25: 695–708
   PubMed Web of Science ®Google Scholar
• Latapi F., Lavalle P. Emploi des sulfones et de l'isoniazide dans le traitement des mycetomes. Memoires du VIII Congress Botanique, Paris 1954; 44–47
   Google Scholar
• Lawson D.H., Paice B.J. Adverse reactions to trimethoprim-sulfamethoxazole. Reviews of Infectious Diseases 1982; 4: 429–433
   PubMedGoogle Scholar
• Maclaren M.L., Mahgoub E.S., Georgakopoulos E. Preliminary investigation of the use of the enzyme linked immunosorbent assay (ELISA) in the serodiagnosis of mycetoma. Sabouraudia 1978; 16: 225–228
   PubMedGoogle Scholar
• Magana M. Mycetoma. International Journal of Dermatology 1984; 23: 221–236
   PubMed Web of Science ®Google Scholar
• Mahgoub E.S. Treatment of actinomycetoma with sulphamethoxazole plus trimethoprim. American Journal of Tropical Medicine and Hygiene 1972; 21: 332–335
   PubMed Web of Science ®Google Scholar
• Mahgoub E.S. Medical management of mycetoma. Bulletin of the World Health Organization 1976; 54: 303–311
   PubMed Web of Science ®Google Scholar
• Mahgoub E.S. Experimental infection of athymic nude new Zealand ‘nu nu’ strain with mycetoma agents. Sabouraudia 1978; 16: 211–216
   PubMedGoogle Scholar
• Mahgoub E.S. Mycetoma. Tropical Fungal infections. Baillières Clinical Tropical Medicine and Communicable Diseases, R.J. Hay. Baillière Tindall, London 1989; 4: 31–44, In
   Google Scholar
• Mahgoub E.S., Gumaa S.A. Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii. Transactions of the Royal Society of Tropical Medicine and Hygiene 1984; 78: 376–369
   PubMed Web of Science ®Google Scholar
• Mahgoub E.S., Gumaa S.A., El. Hassan A.M. Immunological status of mycetoma patients. Bulletin de la Société de Pathologie Exotique 1977; 70: 48–54
   Web of Science ®Google Scholar
• Mahgoub E.S., Murray I.G. Mycetoma. William Heinemann, London 1973
   Google Scholar
• Mandell G.L., Sande M.A. Antimicrobial agents sulfonamides, trimethoprim sulfamethoxazole and agents for urinary tract infections. The Pharmacological Basis of Therapeutics7th edn. Macmillan, New York 1985; 1095–1114, In
   Google Scholar
• Nakae R., Nakae T. Diffusion of aminoglycoside antibiotics across the outer membrane of Escherichia coli. Antimicrobial Agents and Chemotherapy 1982; 22: 554–559
   PubMed Web of Science ®Google Scholar
• Nasher M., Wethered D., Hay R.J., Mahgoub E.S., Gumaa S.A. The ultrastructure of actinomycetoma grains caused by Streptomyces somaliensis. American Journal of Hygiene and Tropical Medicine 1987; 37: 174–179
   PubMed Web of Science ®Google Scholar
• Ortiz-Ortiz L., Bojalil L.F., Contreras M.F. Delayed hypersensitivity to polysaccharides from Nocardia. Journal of Immunology 1972; 108: 1409–1413
   PubMed Web of Science ®Google Scholar
• Sampaio S., Silva Lacaz C. Acao de sulfixozazol na actinomicose provacada eplo Actinomyces brasiliensis. O’Hospital 1965; 50: 795–802
   Google Scholar
• Saul A. Micosis profundas en Lecciones de Dermatologia. Editorial Francisco Mendez Cervantes, Mexico, D. F. 1983; 127–168
   Google Scholar
• Welsh O. Amikacina-Trimethoprim-Sulfamethoxazole en el Tratamiento de Micetomas Actinomicosicos. Tesis Doctoral. Facultad de Medicina de la Universidad Autonoma de Nuevo Leon, MonterreyMexico 1989
   Google Scholar
• Welsh O., Lopez R. Micetomas con diseminacion pulmonar. Medicina Cutanea ILA 1985; 13: 517–523
   PubMedGoogle Scholar
• Welsh O., Sauceda E., Gonzalez J., Ocampo J. Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetoma. Journal of the American Academy of Dermatology 1987; 17: 443–448
   PubMed Web of Science ®Google Scholar
• Wethered D.B., Markey M.A., Hay R.J., Mahgoub E.S., Gumaa S.A. Ultrastructural and immunogenic changes in the formation of mycetoma grains. Journal of Medical and Veterinary Mycology 1987; 25: 39–46
   PubMedGoogle Scholar
• Wethered D.B., Markey M.A., Hay R.J., Mahgoub E.S., Gumaa S.A. Humoral immune responses to mycetoma organisms: characterization of specific antibodies by the use of enzyme-linked immunosorbent assay and immunoblotting. Transactions of the Royal Society of Tropical Medicine and Hygiene 1988; 82: 918–923
   PubMed Web of Science ®Google Scholar
• Wheeler M.H., Bell A.A. Melanins and their importance in pathogenic fungi. Current Topics in Medical Mycology 1988; 2: 338–387
   PubMedGoogle Scholar
• Vipulyasekha S., Vathanabhuti S. Treatment of nocardial mycetoma with sulphamethoxypyridazine. British Journal of Dermatology 1960; 72: 188–191
   PubMed Web of Science ®Google Scholar
• Yousif M.A., Hay R.J. Leucocyte chemotaxis to mycetoma agents — the effect of the antifungal drugs griseofulvin and ketoconazole. Transactions of the Royal Society of Tropical Medicine and Hygiene 1987; 81: 319–321
   PubMed Web of Science ®Google Scholar
• Ziprokowski L., Altmann G., Dalith F., Spitz U. Mycetoma pedis: four cases treated with streptomycin. Archives of Dermatology 1957; 75: 855–863
   Google Scholar